Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer

Gene replacement therapy is an attractive approach for treatment of genetic disease, but may be complicated by the risk of a neutralizing immune response to the therapeutic gene product. There are examples of humoral and cellular immune responses against the transgene product as well as absence of s...

Popoln opis

Bibliografske podrobnosti

izdano v:	J Clin Invest
Principais autores:	Mingozzi, Federico, Liu, Yi-Lin, Dobrzynski, Eric, Kaufhold, Antje, Liu, Jian Hua, Wang, YuQin, Arruda, Valder R., High, Katherine A., Herzog, Roland W.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Clinical Investigation 2003
Teme:	Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC154443/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12727926/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI16887
Oznake:	Označite Brez oznak, prvi označite!